Flow Cytometry is a mainstay of analytical methods to study cells, but growth is now accelerating as new immuno-oncology and liquid biopsy markets create unprecedented investment in the race to cure cancer.  Research vs. Clinical, Bead vs. Gel, its all here in this comprehensive report.
On top of this new genome based knowledge is fostering a new generation of scientific exploration of single cells.  This market just keeps on growing with no end in sight.  The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.
This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.
The technology is moving faster than the market.   Find the opportunities and the pitfalls.  Understand growth expectations and the ultimate potential market size.